Computed Tomography (CT) is a cornerstone of modern medical imaging—enabling detailed, high-speed cross-sectional views critical for emergency triage, oncology staging, and advanced cardiovascular assessments. As healthcare systems worldwide grapple with rising patient volumes and complex diagnostic demands, the CT market remains prime territory for innovation (spectral imaging, photon-counting detectors) and expansion (in both developed and emerging regions).
Yet not all CT scanners or strategies are created equal: from 16-slice workhorses in smaller clinics to ultra-high slice photon-counting or dual-energy systems in top-tier research hospitals, end-user priorities (cost, performance, workflow integration) are evolving. AI-driven recon and scanning protocols increasingly differentiate one manufacturer’s offering from another. Our Markintel Horizon pre-release analysis underscores the multi-billion-dollar scale of the CT market—and reveals which subsegments are poised for breakout growth in the near term.
Target Release: Q2 2025
Our best current estimates peg the Global CT scanner market at around $6.8 billion in 2023, growing at a 6–7% CAGR through 2028. This accounts for new system sales, software upgrades, extended service contracts, and a nascent push into AI-based recon and triage.
Key Demand Drivers:
(Figures remain subject to refinement upon final data validation.)
1. High-Slice Expansion & Photon-Counting Innovations
A significant push is under way for high-slice systems (128-slice and above), driven by the need for faster throughput, superior resolution in complex cardiac or neuro cases, and the ability to reduce radiation dose while preserving diagnostic quality. Many leading OEMs are also racing to commercialize photon-counting CT—a paradigm shift in detector technology that can offer unprecedented spectral data and sharper images. Early adopters in top-tier hospitals and research centers see photon-counting as a means to fine-tune diagnoses (e.g., vascular plaque characterization, dual-energy tissue analysis) and advance personalized patient care. While cost remains a barrier, most market analyses foresee a gradual uptick in photon-counting adoption as advanced hospitals justify the premium for cutting-edge precision and potential long-term ROI.
2. AI-Powered Workflows & Value-Based Care Pressures
Beyond hardware evolution, healthcare organizations are increasingly interested in AI-driven features (automatic scan protocol selection, iterative reconstruction, anomaly detection) to optimize both clinical and operational outcomes. By integrating AI seamlessly into console interfaces or cloud-based solutions, providers can bolster staff productivity, improve consistency, and cut scanning times—satisfying the twin imperatives of cost containment and quality metrics. In many markets, payers and hospital administrators also lean toward value-based care models that penalize inefficiencies like high readmission rates or prolonged ED stays. Consequently, CT scanner investments now revolve around how well the system—and its AI modules—can reduce errors, expedite decisions, and generate meaningful cost savings over the lifecycle of the device. This synergy of technology and value strongly influences buying decisions, intensifying competition among OEMs racing to prove both clinical impact and economic benefit.
Equipment OEMs
AI & Software Ecosystem
Services & Consulting
CT Scanner Installations by Slice Category
Rationale:
Breakdown of CT Procedures by Major Clinical Application
Rationale:
| Title | World Market for CT (Computed Tomography) Scanners — Pre-Release Overview |
| Type | Markintel Horizon (Flagship, In-Depth) |
| Estimated Publication | Q2 2025 (Research & Analysis in progress) |
| Number of Pages | ~200 (Refined with final data) |
| Format | PDF (digital download, direct purchase) |
| Geographical Coverage | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Key Market Segments | – By Slice Category
– By End-User (Hospital vs. Imaging Center) – By Clinical Application (Cardiac, Neuro, etc.) |
| Markintel Frameworks | TEM, ARC Index, M³, GTM Model, TDIT, Opportunity Canvas, MSP (High-level), more |
| Price & Licensing | Individual, Team, Enterprise License |
Disclaimer
This pre-release overview presents best current estimates drawing on Markintel’s frameworks, OEM data, and ongoing interviews with imaging directors worldwide. Final figures, segment definitions, and growth forecasts may be refined prior to the official Q2 2024 publication.
Driving healthcare innovation through actionable intelligence, strategic execution, and transformative solutions for global impact and growth.
